کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2493095 1556614 2016 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب رفتاری
پیش نمایش صفحه اول مقاله
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling
چکیده انگلیسی


• Cerebral hypoxia-ischaemia (HI) induced activation of GSK3β in the neonatal brain.
• Selective inhibition of GSK3β was neuroprotective in neonatal brain injury.
• HI induced activation and nuclear translocation of STAT3 in glial cells.
• GSK3β inhibition reduced oxidative/inflammatory responses via STAT3 downregulation.

Hypoxic-ischaemic (HI) injury is an important cause of neurological morbidity in neonates. HI leads to pathophysiological responses, including inflammation and oxidative stress that culminate in cell death. Activation of glycogen synthase kinase 3β (GSK3β) and the signal transducer and activator of transcription (STAT3) promotes brain inflammation.The purpose of this study was to test whether inhibition of GSK3β signalling protects against neonatal HI brain injury. Mice were subjected to HI at postnatal day (PND) 9 and treated with a selective GSK3β inhibitor, SB216763. Brain injury and caspase-3 activation, anti-oxidant and inflammatory mRNA responses and activation of STAT3 were analysed. Our results show that HI reduced phosphorylation of GSK3β, thus promoting its kinase activity. The GSK3β inhibitor reduced caspase-3 activation and neuronal cell death elicited by HI and reverted the effects of HI on gene expression of the anti-oxidant enzyme sod2 and mitochondrial factor pgc1α. The HI insult activated STAT3 in glial cells and GSK3β inhibition attenuated STAT3 phosphorylation and its nuclear translocation following HI. Further, GSK3β inhibition reduced HI-induced gene expression of pro-inflammatory cytokines tnfα and Il-6, while promoted the anti-inflammatory factor Il-10.In summary, data show that GSK3β inhibition is neuroprotective in neonatal HI brain injury likely via reduced pro-inflammatory responses by blocking STAT3 signalling. Our study suggests that pharmacological interventions built upon GSK3β silencing strategies could represent a novel therapy in neonatal brain injury.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuropharmacology - Volume 101, February 2016, Pages 13–23
نویسندگان
, , , , , ,